✦ LIBER ✦

Entacapone increased duration of symptom relief with levodopa/carbidopa in patient with restless leg syndrome

Book ID: 120863537
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2002
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200213390-00033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P0040 Time of symptom onset and duration

P0040 Time of symptom onset and duration of symptoms: characterization of two patient populations with restless legs syndrome

✍ R.P. Allen; M. Calloway 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 47 KB

P2.092 A randomized, double-blind evalua

P2.092 A randomized, double-blind evaluation of levodopa/carbidopa/entacapone versus immediate-release levodopa/carbidopa in patients with Parkinson's disease exhibiting nonmotor symptoms of wearing off

✍ M. Stacy; K. Mccague; M. Weidenman; A. Campbell; M. Somogyi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Topography of sensory symptoms in patien

Topography of sensory symptoms in patients with drug-naïve restless legs syndrome

✍ Koo, Yong Seo; Lee, Gwan-Taek; Lee, Seo Young; Cho, Yong Won; Jung, Ki-Young 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 609 KB

High prevalence of Dopaminergic Premonit

High prevalence of Dopaminergic Premonitory Symptoms in migraine patients with Restless Legs Syndrome: a pathogenetic link?

✍ Daniela Cologno; Giulio Cicarelli; Vittorio Petretta; Florindo d’Onofrio; Gennar 📂 Article 📅 2008 🏛 Springer Milan 🌐 English ⚖ 43 KB

Lisuride treatment of Restless Legs Synd

Lisuride treatment of Restless Legs Syndrome: first studies with monotherapy in de novo patients and in combination with levodopa in advanced disease

✍ H. Beneš; A. Deissler; A. Rodenbeck; A. Engfer; R. Kohnen 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 73 KB

Cabergoline compared to levodopa in the

Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: Results from a multi-center, randomized, active controlled trial

✍ Claudia Trenkwalder; Heike Benes; Ludger Grote; Svenja Happe; Birgit Högl; Johan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 1 views

## Abstract We report the first large‐scale double‐blind, randomly assigned study to compare two active dopaminergic therapies for Restless Legs Syndrome (RLS), the dopamine agonist cabergoline (CAB) and levodopa/benserazide (levodopa). Patients with idiopathic RLS were treated with fixed daily dos